Radioiodine can be omitted in low-risk disease

被引：0
|
作者：
Romero, Diana
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2022年 / 19卷 / 05期
关键词：
D O I：
10.1038/s41571-022-00625-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [21] Vascular disease: Even low-risk individuals can benefit from statin therapy
    Lim G.B.
    Nature Reviews Cardiology, 2012, 9 (7) : 371 - 371
  • [22] Can single positive core prostate cancer at biopsy be considered a low-risk disease?
    Hayato Yamamoto
    Takuya Koie
    Teppei Ookubo
    Koji Mitsuzuka
    Shintaro Narita
    Takamitsu Inoue
    Sadafumi Kawamura
    Tomoyuki Kato
    Tatsuo Tochigi
    Norihiko Tsuchiya
    Tomonori Habuchi
    Yoichi Arai
    Chikara Ohyama
    International Urology and Nephrology, 2018, 50 : 1829 - 1833
  • [23] Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
    Lamartina, Livia
    Durante, Cosimo
    Filetti, Sebastiano
    Cooper, David S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (05): : 1748 - 1761
  • [24] CAN BREAST IRRADIATION BE OMITTED IN LOW-RISK BREAST-CANCER PATIENTS AFTER SEGMENTECTOMY - 1ST RESULTS OF THE ERLANGEN PROTOCOL
    SAUER, R
    TULUSAN, AH
    LANG, N
    DUNST, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 146 - 147
  • [25] Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the "con" point of view
    Lamartina, Livia
    Cooper, David S.
    ENDOCRINE, 2015, 50 (01) : 67 - 71
  • [26] Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine
    Matrone, Antonio
    Faranda, Alessio
    Latrofa, Francesco
    Gambale, Carla
    Donati, Delio Stefani
    Molinaro, Eleonora
    Agate, Laura
    Viola, David
    Piaggi, Paolo
    Torregrossa, Liborio
    Basolo, Fulvio
    Elisei, Rossella
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (08): : E2845 - E2852
  • [27] Follow-up of Low-Risk Thyroid Cancer Patients Not Submitted to Radioiodine Ablation
    Castro Porto Silva, Carolina Janovsky
    Andreoni, Danielle M.
    Padovani, Rosalia de Prado
    Doimo Nakabashi, Claudia Cristina
    Camacho, Cleber Pinto
    Malouf, Eduardo Zadrozny
    Ikejiri, Elza Setsuko
    Wagner, Jairo
    Maciel, Rui M. B.
    Mello Biscolla, Rosa Paula
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [28] Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the “con” point of view
    Livia Lamartina
    David S. Cooper
    Endocrine, 2015, 50 : 67 - 71
  • [29] A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer
    T. Ben Ghachem
    I. Yeddes
    I. Meddeb
    A. Bahloul
    A. Mhiri
    I. Slim
    M. F. Ben Slimene
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 655 - 660
  • [30] A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer
    Ben Ghachem, T.
    Yeddes, I.
    Meddeb, I.
    Bahloul, A.
    Mhiri, A.
    Slim, I.
    Ben Slimene, M. F.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (02) : 655 - 660
12345